Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application
Disc Medicine Inc. (NASDAQ:IRON) is one of the best biotech stocks to buy according to Wall Street analysts.
Disc Medicine Inc. (IRON)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | 0% | |
| 2. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.00 | 222,223 | $8,000,028.00 | 420,549 | 2024-06-17 | Filing | |
| $36.00 | 10,986 | $395,496.00 | 235,391 | 2024-06-17 | Filing | |
| $36.00 | 43,944 | $1,581,984.00 | 941,569 | 2024-06-17 | Filing | |
| $36.00 | 28,404 | $1,022,544.00 | 608,611 | 2024-06-17 | Filing | |
| $36.00 | 10,986 | $395,496.00 | 235,391 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.66 | 9,700 | $704,795.21 | 54,324 | 2026-06-22 | Filing | |
| $71.62 | 500 | $35,811.00 | 52,173 | 2026-06-18 | Filing | |
| $70.73 | 1,600 | $113,161.12 | 52,673 | 2026-06-18 | Filing | |
| $69.94 | 5,400 | $377,688.42 | 54,273 | 2026-06-18 | Filing | |
| $71.61 | 1,551 | $111,071.14 | 226,064 | 2026-06-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street
Disc Medicine, Inc. (NASDAQ:IRON) is one of the best 52-week high stocks to buy right now. On November 20, analysts at Jefferies reiterated a Buy rating on the stock with a $127 price target.
12 Best 52-Week High Stocks to Buy Right Now
All three major US indices are poised to end the year near record highs in what is turning out to be a blockbuster year for stocks.
10 Best Mid Cap Stocks to Buy According to Billionaires
On July 1, Alan McKnight, the CIO at Regions Wealth Management, appeared on CNBC to explain how his biggest worry is currently centered around uncertainty, which he believes leads to volatility.
Morgan Stanley Assumes Coverage of Disc Medicine (IRON) With $85 PT
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley assumed coverage of the company’s stock with an “Overweight” ...
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
As per the US Bank, the healthcare in the US exhibits a large and intricate ecosystem, which is characterized by size, complexity, and influence on the broader national economy.
Leerink Partners Reiterates a Buy Rating on Disc Medicine (IRON) With an $85 Price Target
Disc Medicine, Inc. (NASDAQ:IRON) is one of the 13 Small Cap Stocks Analysts Are Bullish On.
13 Small Cap Stocks Analysts Are Bullish On
On June 23, Jason Thomas, Carlyle's head of global research and investment strategy, appeared on CNBC’s ‘Squawk Box’ to talk about the state of the market and economy in light of the recent financial...
Hedge Fund Resource Center